Ryosuke Gonotsubo
Head of Business Operations, Japan @ Shinobi Therapeutics
About
Shinobi Therapeutics is developing novel cell therapies using the iPSC to immune cell differentiation technologies for curing cancers, autoimmune and infectious diseases. Led a corporate inversion of Thyas Co. Ltd., a Kyoto company, turning into Shinobi Therapeutics, a global biotech in the USA. Former venture capitalist at Kyoto University Innovation Capital Co., Ltd. ("KYOTO-iCAP"), a university VC firm that invests in startups commercializing Kyoto University's research outcomes. Used to be a manager of Business Development and Investment Innovation Office at Kanematsu Corporation. Led M&As, venture investment and joint venture formation, both domestic and overseas.
Japan
Kyoto
Biotechnology
Cross-border M&A, Finance, Legal, Operation, Licensing, Grassroots Lobbying, Bridging academia - industry , Cross boarder financing deals, Venture Financing, Venture Management, Strategic Planning, Leadership, Valuation, Negotiation, Financial Analysis, Sales, Marketing, Business Strategy, Market Research, Start-ups
Experience
Education
Ryosuke Gonotsubo's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.







